Finding sentinel nodes during mastectomy with dye
Part of Cancer, Skin clinical trials.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage breast cancer (DCIS or invasive T1-T3) that hasn't spread to lymph nodes yet.
- You have had an ultrasound of your armpit to confirm no lymph node spread.
- You are planning a mastectomy and will also have a sentinel lymph node procedure.
- You are 18 years or older.
- You are not allergic to indocyanine green, technetium, contrast dye, or iodine.
- You do not have another active cancer or thyroid disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
This study tests whether a special dye called indocyanine green (ICG) can help find sentinel lymph nodes during breast cancer surgery after chemotherapy. It may offer a safer and more effective way to check if cancer has spread.
This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.
This trial compares two ways to check for cancer spread in the lymph nodes during surgery for esophageal cancer. One way removes more lymph nodes, the other uses a special dye to find and remove only the ones most likely to contain cancer. The goal is to see if the dye method works just as well with fewer side effects.
This trial is testing a technique that uses a special dye to find the first lymph nodes where ovarian cancer might spread. It aims to help doctors remove only those sentinel nodes during surgery instead of removing many nodes, which could lead to fewer side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.